TriSalus Life Sciences Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | +47.6% | +49.3% | +59.0% | +53.4% | |
| – | +89.3% | +15.4% | +57.5% | +69.8% | |
| – | +40.7% | +56.9% | +59.2% | +50.8% | |
| – | +50.2% | +39.7% | -40.7% | -15.4% | |
| – | +42.6% | +88.4% | -23.6% | +19.4% | |
| – | +49.1% | +51.1% | -12.6% | +5.9% | |
| – | – | – | – | – | |
| – | -99.9% | +1,500.0% | +19,212.5% | +79.4% | |
| – | – | – | – | – | |
| – | +200.0% | +0.0% | -33.3% | +16.7% | |
| – | – | – | – | – | |
| – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.